Title
Author
DOI
Article Type
Special Issue
Volume
Issue
Biological and pathological features in pregnancy-associated breast cancer: a matched case-control study
1Gynecologic Oncology and Breast Pathology Section, Department of Obstetrics, Gynecology and Human Reproduction Hospital Universitari Quirón Dexeus, Barcelona, Spain
2Department of Pathology, Department of Obstetrics, Gynecology and Human Reproduction Hospital Universitari Quirón Dexeus, Barcelona, Spain
3Statistics and Epidemiology Unit, Department of Obstetrics, Gynecology and Human Reproduction Hospital Universitari Quirón Dexeus, Barcelona, Spain
4Gynecologic Diagnostic Imaging, Department of Obstetrics, Gynecology and Human Reproduction Hospital Universitari Quirón Dexeus, Barcelona, Spain
*Corresponding Author(s): S. Baulies E-mail: sonbau@dexeus.com
Background: The prognosis for breast cancer has been considered to be worsened by the coexistence of pregnancy. However, to date, significant controversy still exists regarding the pathological tumor features and prognosis of patients diagnosed with pregnancy-associated breast cancer (PABC). The aim of the present study was to analyze the different prognostic factors and outcome in PABC subset versus a non-PABC control group matched for age and year of diagnosis. Materials and Methods: A total of 56 PABC cases were diagnosed from 1990 to 2008, for whom 73 non-PABC patients were identified. Pathological characteristics, immunohistochemical features, and differences in overall and disease-free survival were compared between both groups. Results: Compared to non-PABC controls, PABC patients presented more advanced disease (31% vs 13%, p = 0.024) and greater lymph node involvement (53% vs 34%, p = 0.034). Pathological and tumor features tended to present poorer prognostic factors in the PABC subset. Survival was poorer in the PABC patients (five-year DFS 68% in PABC vs 86% in non-PABC, p = 0.12). However, analysing survival adjusted for stage and age, the authors did not find significant differences between both groups. Conclusions: PABC patients tended to be diagnosed in advanced breast disease and presented tumors with adverse pathological prognostic factors. While the authors found a poorer outcome in PABC group, no significant differences were observed with stage-matched analysis. The present results may suggest that the poorer prognosis observed within PABC women could not be due to pregnancy itself, but with a delay in diagnosis and tumor subtype pathological features.
Breast cancer; Pregnancy; Prognostic factors; Outcome; Pathological features.
S. Baulies,M. Cusidó,F. Tresserra,F. Fargas,I. Rodríguez,B. Úbeda,C. Ara,R. Fábregas. Biological and pathological features in pregnancy-associated breast cancer: a matched case-control study. European Journal of Gynaecological Oncology. 2015. 36(4);420-423.
[1] Johansson A.L., Andersson T.M., Hsieh C.C., Cnattingius S., Lambe M.: “Increased mortality in women with breast cancer detected during pregnancy and different periods postpartum”. Cancer Epidemiol. Biomarkers Prev., 2011, 20, 1865.
[2] Britt K., Ashworth A., Smalley M.: “Pregnancy and the risk of breast cancer”. Endocr. Relat. Cancer, 2007, 14, 907.
[3] Anderson J.M.: “Mammary cancers and pregnancy”. Br. Med. J., 1979, 1, 1124.
[4] Danforth D.N. Jr.: “Breast cancer during pregnancy: a comprehensive review”. Cancer J., 2010, 16, 68.
[5] Murphy C.G., Mallam D., Stein S., Patil S., Howard J., Sklarin N., et al.: “Current or recent pregnancy is associated with adverse pathological features but not impaired survival in early breast cancer”. Cancer, 2012, 118, 3254.
[6] Ribeiro G., Jones D.A., Jones “.: :Carcinoma of the breast associated with pregnancy”. Br. J. Surg., 1986, 73, 607.
[7] Daling J.R., Malone K.E., Doody D.R., Anderson B.O., Porter P.L.: “The relation of productive factors to mortality from breast cancer”. Cancer Epidemiol. Biomarkers Prev., 2002, 11, 235.
[8] Jacobsen B.M., Schittone S.A., Richer J.K., Horwitz K.B.: “Progesterone- independent effects of human progesterone receptors in estrogen receptor-positive breast cancer”. Mol. Endocrinol., 2005, 19, 574.
[9] Schedin P.: “Pregnancy-associated breast cancer and metastasis”. Nat. Rev. Cancer, 2006, 6, 281.
[10] Hanahan D., Weinberg R.: “The Hallmarks of cancer”. Cell, 2000, 100, 57.
[11] Guinee V.F., Olsson H., Moller T., Hess K.R., Taylor S.H., Fahey T., et al.: “Effect of pregnancy on prognosis for young women with breast cancer”. Lancet, 1994, 343, 1587.
[12] Theriault R., Hahn K.: “Management of breast cancer in pregnancy”. Curr. Oncol. Rep., 2007, 9, 17.
[13] Donegan W.L.: “Breast carcinoma and pregnancy”. In: Donegan W.L., Spratt J.S., (eds). Cancer of the breast, 4th ed. Philadelphia:PA: Saunders, 1995, 732.
[14] Johansson A.L., Andersson T.M.L., Hsieh C.C., Jirström K., Dickman P., Cnattingius S., et al.: “Stage at diagnosis and mortality in women with pregnancy-associated breast cancer (PABC)”. Breast Cancer Res. Treat., 2013, 139, 183.
[15] Azim H.A. Jr. , Botteri E., Renne G., Dell’Orto P., Rotmensz N., Gentilini O., et al.: “The biological features and prognosis of breast cancer diagnosed during pregnancy: a case-control study”. Acta Oncol., 2012, 51, 653.
[16] Azim H.A. Jr., Santoro L., Russell-Edu W., Pentheroudakis G., Pavlidis N., Peccatori F.A.: “Prognosis of pregnancy-associated breast cancer: a meta-analysis of 30 studies”. Cancer Treat. Rev., 2012, 38, 834.
[17] Amant F.,Von Minckwitz G., Han S.N., Botenbal M., Ring A.E., Giermerk J., et al.: “Prognosis of women with primary breast cancer diagnosed during pregnancy: results from an international collaborative study”. J. Clin. Oncol., 2013, 20, 2532.
[18] Elston C.W., Ellis I.O.: “Pathological prognostic factors in breast cancer. I. The value of histological grade in breast cancer: experience from a large study with long-term follow-up”. Histopathology, 1991, 19, 403.
[19] Haagensen C.D., Stout A.P.: “Carcinoma of the breast: II. Criteria of operability”. Ann. Surg., 1943, 118, 859.
[20] Theriault R., Hahn K.: “Management of breast cancer in pregnancy”. Curr. Oncol. Rep., 2007, 9, 17.
[21] Middleton L.P., Amin M., Gwyn K., Theriault R., Sahin A.: “Breast carcinoma in pregnant women: assessment of clinicopathologic and immunohistochemical features”. Cancer, 2003, 98, 1055.
[22] Halaska M.J., Pentheroudakis G., Strnad P., Stankusova H., Chod J., Robova H., et al.: “Presentation, management and outcome of 32 patients with pregnancy-associated breast cancer: a matched controlled study”. Breast J., 2009, 15, 461.
[23] Beadle B.M., Woodward W.A., Middleton L.P., Tereffe W., Strom E.A., Litton J.K., et al.: “The impact of pregnancy on breast cancer outcomes in women <or=35 years”. Cancer, 2009, 115, 1174.
[24] Rodriguez A.O., Chew H., Cress R., Xing G., McElvy S., Danielsen B., et al.: “Evidence of poorer survival in pregnancy-associated breast cancer”. Obstet. Gynecol., 2008, 112, 71.
[25] Merino M.J., Middleton L.P., Grases P.J., Tresserra F.: “Breast cancer and pregnancy”. Lab Inv., 1996, 74, 20A.
[26] Shannon C., Smith I.E.: “Breast cancer in adolescents and young women”. Eur. J. Cancer, 2003, 39, 2632.
Top